Development of GMI-1359, a novel agent targeting tumor-microenvironment cross-talk in bone metastatic cancer

Article Details

Citation

Copy to clipboard

P. Kelly Marcom, Trevor T. Price, Andrew S. Murray, William E. Fogler, John L. Magnani, Helen Thackray, Eric Feldman, Dorothy Sipkins

Development of GMI-1359, a novel agent targeting tumor-microenvironment cross-talk in bone metastatic cancer

Cancer Res. 2021 July 1;81(13):CT144.

PubMed ID

Not Available

Abstract

Not Available

DrugBank Data that Cites this Article

Drugs

GMI-1359